Peptide Therapeutics
10 articles on Peptide Therapeutics, written by Shotlee and medically reviewed for clinical accuracy.
Beyond Ozempic: Exploring the Expanding World of Peptide Therapeutics
Peptides are making waves in health and wellness, driven by the success of medications like Ozempic. This article delves into what peptides are, their growing applications, and the exciting future of peptide therapy.
8 min read
Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation
The GLP-1 revolution is just the beginning. This article delves into the cutting-edge advancements poised to reshape the future of weight loss and metabolic health, offering insights for patients and observers alike.
7 min read
Retatrutide: The Next Wave in Metabolic Peptide Therapy?
Discover Retatrutide, a groundbreaking peptide with triple-receptor activity, poised to redefine metabolic health and weight management strategies. Learn about its science, potential, and what it means for the future of wellness.
8 min read
Arecor CEO on FY25 Highlights: AT278 & GLP-1 Progress
Arecor Therapeutics is advancing AT278, the only ultra-concentrated, ultra-rapid-acting insulin optimized for automated insulin delivery systems, addressing key limitations in current therapies. CEO Sarah Howell shares progress on a US Phase 2 trial partnership and oral GLP-1 platform developments. With a strengthened balance sheet, the company eyes major milestones in diabetes and cardiometabolic treatments.
4 min read
Ozempic and Weight-Loss Drugs Create Hidden Waste Disaster
The boom in weight-loss drugs like Ozempic is fueling a hidden environmental crisis, with production generating up to 120 million pounds of toxic solvent waste annually. Traditional solid-phase peptide synthesis relies on hazardous chemicals, but a groundbreaking water-based approach could eliminate this issue. Researchers have demonstrated a cleaner method matching traditional yields.
4 min read
Peptide Gold Rush: Deregulation Set to Supercharge Shadow Industry
Peptides, once a Silicon Valley biohacking secret, are exploding in popularity—search interest now tops Ozempic. With RFK Jr. poised to reverse FDA restrictions, compounding pharmacies and telehealth platforms are racing to supply them legally. This could propel the $52B peptide market to $87B by 2035.
5 min read
Peptide Therapy Guide: GLP-1s, Benefits & Risks
Peptide therapy has surged in popularity, driven by GLP-1 drugs like Ozempic and Wegovy that transform weight management and metabolic health. This guide breaks down the science, approved uses, potential benefits, and critical risks. Gain evidence-based insights to make informed decisions.
4 min read
Peptide Therapeutics Market to Hit USD 82.19 Billion by 2032 Amid Rising Demand for Oncology Medicines: SNS Insider
The global Peptide Therapeutics Market is experiencing substantial growth, projected to reach USD 82.19 billion by 2032. This expansion is fueled by the increasing need for specialized medications, particularly in oncology and metabolic diseases. The U.S. market is expected to reach USD 35.71 billion by 2032.
4 min read
Peptide CDMO 2.0 Market Outlook to 2034: Emphasizing Integrated and Tech-Forward CDMOs
The global peptide CDMO 2.0 market is poised for substantial growth, driven by increasing demand for peptide therapeutics and advancements in manufacturing technologies. This growth is fueled by the need for flexible, scalable, and efficient peptide production to meet the demands of both established pharmaceutical companies and emerging biotechs.
6 min read
Oral Proteins & Peptides Market to Reach USD 47.2 Billion Globally by 2035, Exhibiting 15.3% CAGR - TMR Study
The global market for oral proteins and peptides is experiencing rapid expansion, with projections estimating a value of US$ 47.2 billion by 2035. This growth, driven by increasing demand for peptide-based therapeutics and advancements in delivery technologies, signifies a dynamic shift in the pharmaceutical and nutraceutical landscape.
6 min read